| NO | JUDUL | PENELITI |
| 1. | Clinical outcomes study to compare the effect of fluticasone furoate / Vilanterol inhalation powder 100/25 mcq with placebo on survival in subjects with subjects with moderate chronic obstructive pulmonary disease (COPD) and a history of or at increased risk for cardio vascular disease (SUMMIT Study) | Peneliti Utama : Prof. Dr. dr. Moh. Amin, Sp.P(K) Peneliti Pendamping : Dr.dr.Daniel Maranatha, Sp.P(K) |
| 2. | A Randomised, paralel group, open label, multicentre, 3 month phase IV, efficacy and tolerability study of budesonide/for moterol (symbicont turbuhaler 160/4.5mg/inhalation, 2 inhalatim twice daily) added to tiotropium (spiriva TM 18mg/inhalation, inhalation once daily) compared with to tiotropium (spiriva TM 18mg/inhalation, inhalation once daily) alone in severe chronic pulmonary disease (COPD) patients. | Peneliti Utama : Prof. Dr. dr. Moh. Amin, Sp.P(K) Peneliti Pendamping : Dr.dr. Daniel Maranatha, Sp.P(K) |
| 3. | A diagnostic study to determine the prevelance of EGFR mutation in Asian and Russian patients with advanced NSCLC (a NSCLC) of adeno Carcinoma and Non Adeno Carcinoma Histologist (IGNITE Study) | Peneliti Utama : dr. Laksmi Wulandari, Sp.P(K) Peneliti Pendamping : dr. Tutik K, Sp.P |
| 4. | A prospective, randomited, multicenter, open label, 3 month phase III study of active spesific imunotheraphy with Racotumomab plus best support treatment versus best support treatment in patients with advanced non small cell lung cancer. (Racotumomab Study) | Peneliti Utama : dr. Laksmi Wulandari, Sp.P(K) Peneliti Pendamping : dr. Tutik K, Sp.P |
| 5. | A Randomised, placebo, controlled, double blind phase III study of intercalated traceva (Erlotinib) or placebo with gemicitabine or platinum of first lin treartment in patients with stage III or IV non small cell lung cancer. (Fact Act is Study). | Peneliti Utama : dr. Laksmi Wulandari, Sp.P(K) Peneliti Pendamping : dr. Tutik K, Sp.P |
| 6. | Program kerjasama untuk meningkatkan pelaksanaan TB DOTS di DKK Surabaya, Kerjasama dengan BKKM FK Unair. | dr. Soedarsono, Sp.P, dr. Laksmi Wulandari, Sp.P(K), dr. Prastuti Asta N, Sp.P |
| 7. | Bertugas di Puskesmas Pegirian dan Puskesmas Kedurus | dr. Arief Bachtiar, Sp.P., dr.Isnin Anang M., Sp.P |
| 8. | Open label randomized, multicentre study to compare clinical efficacy and safety of levofleoxacin (75g IV - oral one daily) to moxifloxacin (400g IV-oral one daily) in hospitalizzed patients with moderate to serve community acquired pnemonia in Indonesia. | Peneliti Utama : dr. Soedarsono, Sp.P(K) Peneliti Pendamping : dr. Laksmi Wulandari, Sp.P(K), dr. Resti Yudhawati M, Sp.P |
informasi lengkap mohon silakan menghubungi Dept. Pulmonologi & Kedokteran Respirasi 031-5501656
Add new comment
